We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · May 12, 2022

Postmastectomy Radiotherapy Improves Survival Benefits in De Novo Stage IV Breast Cancer

Technology in Cancer Research & Treatment

 

Additional Info

Disclosure statements are available on the authors' profiles:

Technology in Cancer Research & Treatment
Postmastectomy Radiotherapy Improves Survival Benefits in De Novo Stage IV Breast Cancer: A Propensity-Score Matched Analysis
Technol. Cancer Res. Treat. 2022 Jan 01;21(2022)15330338221089937, X Wang, N Liang, T Tian, J Zhang, P Hu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading